UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Ingredient xmlns="http://hl7.org/fhir">
<id value="Yasminelle28-tablet-SE-AJ-ING01"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Ingredient Yasminelle28-tablet-SE-AJ-ING01</b></p><a name="Yasminelle28-tablet-SE-AJ-ING01"> </a><a name="hcYasminelle28-tablet-SE-AJ-ING01"> </a><a name="hcYasminelle28-tablet-SE-AJ-ING01-en-US"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href="MedicinalProductDefinition-Yasminelle28-tablet-SE-AJ-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100004813-00023086,http://ema.europa.eu/fhir/eurdId#10217; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Film-coated tablet; indication = Antikonception Vid beslut att förskriva Yasminelle 28 ska den enskilda kvinnans riskfaktorer beaktas, framför allt de för venös tromboembolism (VTE), och risken för VTE med Yasminelle 28 jämfört med andra kombinerade hormonella preventivmedel (se avsnitt 4.3 och 4.4).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = drospirenone and ethinylestradiol</a></li><li><a href="ManufacturedItemDefinition-Yasminelle28-tablet-SE-AJ-MID01.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Film-coated tablet; unitOfPresentation = tablet</a></li><li><a href="AdministrableProductDefinition-Yasminelle28-tablet-SE-AJ-APD01.html">AdministrableProductDefinition: status = active; administrableDoseForm = Film-coated tablet</a></li></ul><p><b>role</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091531}">Ethinylestradiol betadex clathrate</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 173.17 microgram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000091721}">Ethinylestradiol</span></td></tr></table><p><b>strength</b>: 20 microgram(s)<span style="background: LightGoldenRodYellow"> (Details: Unit of Measurement EMA code100000110656 = 'microgram(s)')</span>/1 tablet<span style="background: LightGoldenRodYellow"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>
</text>
<status value="active"/>
<for>🔗
<reference
value="MedicinalProductDefinition/Yasminelle28-tablet-SE-AJ-MPD"/>
</for>
<for>🔗
<reference
value="ManufacturedItemDefinition/Yasminelle28-tablet-SE-AJ-MID01"/>
</for>
<for>🔗
<reference
value="AdministrableProductDefinition/Yasminelle28-tablet-SE-AJ-APD01"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072050"/>
<code value="100000072072"/>
<display value="Active"/>
</coding>
</role>
<substance>
<code>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091531"/>
<display value="Ethinylestradiol betadex clathrate"/>
</coding>
</concept>
</code>
<strength>
<presentationRatio>
<numerator>
<value value="173.17"/>
<unit value="microgram(s)"/>
<system value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110656"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</presentationRatio>
<referenceStrength>
<substance>
<concept>
<coding>
<system
value="https://spor.azure-api.net/sms/api/v2/SubstanceDefinition"/>
<code value="100000091721"/>
<display value="Ethinylestradiol"/>
</coding>
</concept>
</substance>
<strengthRatio>
<numerator>
<value value="20"/>
<unit value="microgram(s)"/>
<system value="https://spor.ema.europa.eu/v1/lists/100000110633"/>
<code value="100000110656"/>
</numerator>
<denominator>
<value value="1"/>
<unit value="tablet"/>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002152"/>
</denominator>
</strengthRatio>
</referenceStrength>
</strength>
</substance>
</Ingredient>